miR-93-5p promotes insulin resistance to regulate type 2 diabetes progression in HepG2 cells by targeting HGF

Man Zhou1, Yilin Hou1, Jun Wu1

  • 1Department of Endocrinology, Wuhan Third Hospital, Wuhan, Hubei 430060, P.R. China.

Insights

MicroRNA-93-5p enhances insulin resistance in type 2 diabetes by targeting hepatocyte growth factor in liver cells. This finding provides new insights into T2DM mechanisms and potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Endocrinology
  • Cell Biology

Background:

  • Insulin resistance is a key feature of type 2 diabetes mellitus (T2DM), but its underlying mechanisms remain incompletely understood.
  • MicroRNAs (miRNAs) play crucial roles in regulating cellular processes, including metabolism and disease pathogenesis.

Purpose of the Study:

  • To investigate the role of microRNA (miR)-93-5p in the development of insulin resistance in T2DM.
  • To elucidate the molecular mechanism by which miR-93-5p influences insulin resistance in hepatocellular carcinoma (HepG2) cells.

Main Methods:

  • Established an in vitro insulin-resistant HepG2 cell model using high glucose conditions.
  • Assessed glucose consumption, glycogen synthesis, cell viability, proliferation, and apoptosis.
  • Quantified miR-93-5p and hepatocyte growth factor (HGF) expression, and investigated their interaction using RT-qPCR, western blotting, and dual-luciferase reporter assays.

Main Results:

  • miR-93-5p expression was significantly increased, while HGF expression was decreased in T2DM liver tissues and insulin-resistant HepG2 cells.
  • Overexpression of miR-93-5p enhanced proliferation, glucose consumption, and glycogen synthesis, while inhibiting apoptosis in insulin-resistant HepG2 cells.
  • HGF overexpression exhibited opposite effects, and miR-93-5p's effects were partially abrogated by HGF co-expression, indicating HGF as a target.

Conclusions:

  • miR-93-5p exacerbates insulin resistance in HepG2 cells by targeting and downregulating HGF.
  • This miR-93-5p/HGF axis represents a potential regulatory pathway in T2DM progression.
  • Findings suggest miR-93-5p as a potential therapeutic target for managing insulin resistance in T2DM.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
14.6K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K